The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 28193700)

Published in J Cell Biol on February 13, 2017

Authors

Muhan Chen1, Dawid G Nowak1, Navneet Narula2,3, Brian Robinson2,3, Kaitlin Watrud1, Alexandra Ambrico1, Tali M Herzka1, Martha E Zeeman1, Matthias Minderer1, Wu Zheng1, Saya H Ebbesen1,4, Kendra S Plafker5, Carlos Stahlhut1, Victoria M Y Wang1, Lorna Wills1, Abu Nasar6, Mireia Castillo-Martin7, Carlos Cordon-Cardo7, John E Wilkinson8, Scott Powers1, Raffaella Sordella1, Nasser K Altorki6, Vivek Mittal6, Brendon M Stiles6, Scott M Plafker5, Lloyd C Trotman9

Author Affiliations

1: Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724.
2: Department of Pathology, Neuberger Berman Lung Cancer Research Center, New York-Presbyterian Hospital, Weill Cornell Medical College, New York, NY 10065.
3: Department of Cell and Developmental Biology, Neuberger Berman Lung Cancer Research Center, New York-Presbyterian Hospital, Weill Cornell Medical College, New York, NY 10065.
4: The Watson School of Biological Sciences, Cold Spring Harbor, NY 11724.
5: Free Radical Biology and Aging Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.
6: Department of Cardiothoracic Surgery, Neuberger Berman Lung Cancer Research Center, New York-Presbyterian Hospital, Weill Cornell Medical College, New York, NY 10065.
7: Department of Pathology, Mount Sinai Medical School, New York, NY 10029.
8: Department of Pathology, University of Michigan, Ann Arbor, MI 48109.
9: Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724 trotman@cshl.edu.

Articles citing this

Importin-11 keeps PTEN safe from harm. J Cell Biol (2017) 0.75

Articles cited by this

Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (1997) 29.34

Integrative genomic profiling of human prostate cancer. Cancer Cell (2010) 23.61

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature (2005) 15.83

The genomic complexity of primary human prostate cancer. Nature (2011) 14.06

Transport between the cell nucleus and the cytoplasm. Annu Rev Cell Dev Biol (1999) 13.27

The mutational landscape of lethal castration-resistant prostate cancer. Nature (2012) 11.82

Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A (1999) 7.88

Pten dose dictates cancer progression in the prostate. PLoS Biol (2003) 7.62

The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol (2012) 7.32

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet (2009) 7.26

Protein import into nuclei: association and dissociation reactions involving transport substrate, transport factors, and nucleoporins. Cell (1995) 6.97

Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med (2009) 6.61

Inhibition of nuclear protein import by nonhydrolyzable analogues of GTP and identification of the small GTPase Ran/TC4 as an essential transport factor. J Cell Biol (1993) 6.47

Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods (2014) 5.76

Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell (2007) 5.62

Catalysis of guanine nucleotide exchange on Ran by the mitotic regulator RCC1. Nature (1991) 5.39

Integrative clinical genomics of advanced prostate cancer. Cell (2015) 5.29

NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell (2007) 5.20

PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer (2011) 4.37

Subtle variations in Pten dose determine cancer susceptibility. Nat Genet (2010) 4.19

Karyopherins and nuclear import. Curr Opin Struct Biol (2001) 3.53

A continuum model for tumour suppression. Nature (2011) 3.48

A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. J Clin Invest (2010) 3.47

The Molecular Taxonomy of Primary Prostate Cancer. Cell (2015) 3.29

PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol (2012) 3.11

Chromosome- and spindle-pole-derived signals generate an intrinsic code for spindle position and orientation. Nat Cell Biol (2012) 3.08

Pro-senescence therapy for cancer treatment. Nat Rev Cancer (2011) 2.75

Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc Natl Acad Sci U S A (2001) 2.50

Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer. Nature (2014) 1.88

Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. J Clin Invest (2007) 1.86

N4WBP5, a potential target for ubiquitination by the Nedd4 family of proteins, is a novel Golgi-associated protein. J Biol Chem (2001) 1.84

Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas. Clin Cancer Res (1998) 1.83

E3 ligase Nedd4 promotes axon branching by downregulating PTEN. Neuron (2010) 1.76

Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression. Cancer Cell (2011) 1.74

PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. Hum Pathol (2005) 1.67

Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer. Cancer Res (2008) 1.58

The phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling. Cancer Res (2010) 1.41

Copy number alteration burden predicts prostate cancer relapse. Proc Natl Acad Sci U S A (2014) 1.38

Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs. Mol Biol Cell (2006) 1.38

Non-genomic loss of PTEN function in cancer: not in my genes. Trends Pharmacol Sci (2011) 1.36

Importin-11, a nuclear import receptor for the ubiquitin-conjugating enzyme, UbcM2. EMBO J (2000) 1.34

Ubiquitin charging of human class III ubiquitin-conjugating enzymes triggers their nuclear import. J Cell Biol (2004) 1.33

Role of RAS in the regulation of PI 3-kinase. Curr Top Microbiol Immunol (2010) 1.27

Ndfip1 regulates nuclear Pten import in vivo to promote neuronal survival following cerebral ischemia. J Cell Biol (2012) 1.13

Identification of a nuclear export signal in the catalytic subunit of AMP-activated protein kinase. Mol Biol Cell (2010) 1.10

Modeling prostate cancer in mice: something old, something new, something premalignant, something metastatic. Cancer Metastasis Rev (2013) 1.08

Signaling networks associated with AKT activation in non-small cell lung cancer (NSCLC): new insights on the role of phosphatydil-inositol-3 kinase. PLoS One (2012) 1.06

Nuclear import/export of hRPF1/Nedd4 regulates the ubiquitin-dependent degradation of its nuclear substrates. J Biol Chem (2001) 1.05

Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma. J Thorac Oncol (2012) 0.94

RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis. Cancer Discov (2014) 0.93

Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma. Lung Cancer (2011) 0.89

Targeting phosphoinositide 3-kinase signalling in lung cancer. Crit Rev Oncol Hematol (2011) 0.87

MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2. Cancer Discov (2015) 0.85

Disruption of E3 ligase NEDD4 in peripheral neurons interrupts axon outgrowth: Linkage to PTEN. Mol Cell Neurosci (2012) 0.84

Nuclear trafficking of Pten after brain injury leads to neuron survival not death. Exp Neurol (2013) 0.83

PTEN plasticity: how the taming of a lethal gene can go too far. Trends Cell Biol (2013) 0.82

In Cell and In Vitro Assays to Measure PTEN Ubiquitination. Methods Mol Biol (2016) 0.80

Rapid in vivo validation of candidate drivers derived from the PTEN-mutant prostate metastasis genome. Methods (2015) 0.79